U.S. House · 118th Congress · H.R. 4134

Updated Drug Labeling for Patient Safety Act

To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information, and for other purposes.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Adam B. SchiffD-CA-30
Introduced
June 14, 2023, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (3)

3 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these

Original cosponsors

Signed on later